SBI Research warns that a planned 50% tax on Indian pharmaceutical exports could cut profits and hurt India's important role…
With the US imposing steep copper tariffs and hinting at a 200% levy on pharmaceuticals, India’s $10 billion export sectors…
India, the top supplier of generic drugs to the US, could face major setbacks as Trump targets pharmaceutical imports with…
The Indian Medical Association (IMA) has shown concern over the latest guidelines issued by National Medical Commission (NMC) prescribing generic…
